John A. Valenta

566 total citations
5 papers, 437 citations indexed

About

John A. Valenta is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, John A. Valenta has authored 5 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Hematology and 1 paper in Genetics. Recurrent topics in John A. Valenta's work include Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). John A. Valenta is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). John A. Valenta collaborates with scholars based in United States. John A. Valenta's co-authors include Brian W. Kwan, Thomas K. Wood, Michael J. Benedik, Santhana G.T. Devaraj, Warren Fiskus, Sunil Sharma, Swaminathan P. Iyer, Jun Qi, Bhavin Shah and Kapil N. Bhalla and has published in prestigious journals such as Blood, Antimicrobial Agents and Chemotherapy and Molecular Cancer Therapeutics.

In The Last Decade

John A. Valenta

5 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John A. Valenta United States	2	319	147	103	75	72	5	437
Hazel F. O’Connor United States	7	208 0.7×	116 0.8×	79 0.8×	70 0.9×	19 0.3×	9	324
Konstantin Byrgazov Austria	9	433 1.4×	224 1.5×	31 0.3×	26 0.3×	116 1.6×	20	598
S Sawada Japan	12	213 0.7×	67 0.5×	31 0.3×	28 0.4×	97 1.3×	16	479
Angel C.Y. Yu Canada	8	205 0.6×	183 1.2×	39 0.4×	133 1.8×	9 0.1×	8	437
Robert Bever United States	6	285 0.9×	169 1.1×	31 0.3×	32 0.4×	12 0.2×	8	436
Jason Larson United States	7	118 0.4×	72 0.5×	33 0.3×	39 0.5×	46 0.6×	8	382
Filipa P. Reis Portugal	8	677 2.1×	171 1.2×	13 0.1×	31 0.4×	24 0.3×	15	799
Kimberley D. Gutierrez United States	6	281 0.9×	75 0.5×	18 0.2×	31 0.4×	11 0.2×	6	453
Sandra L. Drake United States	6	217 0.7×	137 0.9×	18 0.2×	38 0.5×	9 0.1×	8	405
Krishna Kurthkoti India	13	254 0.8×	68 0.5×	72 0.7×	12 0.2×	27 0.4×	19	507

Countries citing papers authored by John A. Valenta

Since Specialization

Citations

This map shows the geographic impact of John A. Valenta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Valenta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Valenta more than expected).

Fields of papers citing papers by John A. Valenta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Valenta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Valenta. The network helps show where John A. Valenta may publish in the future.

Co-authorship network of co-authors of John A. Valenta

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Valenta. A scholar is included among the top collaborators of John A. Valenta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Valenta. John A. Valenta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Fiskus, Warren, Sunil Sharma, Jun Qi, et al.. (2014). Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells. Molecular Cancer Therapeutics. 13(5). 1142–1154. 155 indexed citations

2.

Kwan, Brian W., John A. Valenta, Michael J. Benedik, & Thomas K. Wood. (2013). Arrested Protein Synthesis Increases Persister-Like Cell Formation. Antimicrobial Agents and Chemotherapy. 57(3). 1468–1473. 279 indexed citations

3.

Fiskus, Warren, Sunil Sharma, Jun Qi, et al.. (2013). BRD4 Antagonist and Histone Deacetylase Inhibitor: A Novel Synergistic Combination Against Human Acute Myeloid Leukemia (AML) Cells. Blood. 122(21). 485–485. 1 indexed citations

4.

Rodríguez, Melissa, Warren Fiskus, Sunil Sharma, et al.. (2013). Combined Therapy With BRD4 Antagonist and FLT3 Inhibitor Exerts Synergistic Activity Against Cultured and Primary AML Blast Progenitors Expressing FLT-ITD. Blood. 122(21). 3821–3821. 1 indexed citations

5.

Valenta, John A., Warren Fiskus, Taghi Manshouri, et al.. (2013). Combined Therapy With BRD4 Antagonist and JAK Inhibitor Is Synergistically Lethal Against Human Myeloproliferative Neoplasm (MPN) Cells. Blood. 122(21). 2842–2842. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact